YOLFTbeta
CareRay Digital Medical Technology Co Ltd

CareRay Digital Medical Technology Co Ltd

688607 · SHG · Healthcare / Medical Devices

35.26CNY-2.06 (-5.52%)

Price History

Full chart

Market Stats

Previous Close37.32
Open37.88
Day Range35.00 – 37.88
52-Week Range25.80 – 73.00
Volume1.47M
Market Cap3.13B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.34
Dividend Yield0.00%
Beta0.43
50-Day Avg40.22
200-Day Avg51.72

About

CareRay Digital Medical Technology Co., Ltd. engages in research and development, production, and sales of digital X-ray flat panel detectors in China, the United States, India, Japan, and internationally. The company offers Gen3 panels; radiography products, including wireless, tethered, and specialized panels, as well as accessories; mammography, fluoroscopy, dental, and industrial NDT products; and custom panels. It also provides solutions for retrofit and OEMS; precision low dose care; dynamic DR; and customized solutions. The company's products are used for clinical examinations, such as medical radiographs, breast examinations, fluoroscopy, and pet medical treatment, as well as treatment of radiotherapy and interventional surgery. CareRay Digital Medical Technology Co., Ltd. was founded in 2007 and is headquartered in Suzhou, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Jianqiang Liu
  • Employees294
  • HeadquartersNo. 15, Songbei Road, Suzhou, China, 215024, China
  • Websitehttps://www.careray.cn

Leadership

  • Mr. Jianqiang LiuChairman, CEO & Founder · b. 1962
  • Ms. Ping ZhangCFO & Director · b. 1979
  • Mr. Peng GaoDeputy GM & Director · b. 1964
  • Mr. Ruping YangDeputy General Manager · b. 1966
  • Feng XuAccounting Supervisor

Financials

Income Statement

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue198.02M212.75M234.55M339.22M341.98M204.57M273.74M298.10M320.53M
Growth (%)-+7.44%+10.25%+44.63%+0.81%-40.18%+33.81%+8.90%+7.52%
Cost of Revenue114.87M113.27M131.90M193.21M185.19M140.88M172.69M185.59M203.30M
Gross Profit83.16M99.48M102.65M146.01M156.79M63.69M101.05M112.51M320.53M
Gross Margin41.99%46.76%43.76%43.04%45.85%31.13%36.92%37.74%100.00%
Operating Expense55.66M44.37M48.14M60.30M63.46M73.89M87.22M94.93M331.28M
Operating Income27.50M55.11M54.51M85.71M93.33M-10.20M13.83M17.58M-10.76M
Operating Margin13.89%25.90%23.24%25.27%27.29%-4.99%5.05%5.90%-3.36%
EBITDA30.41M59.42M62.41M94.31M102.60M-2.03M22.11M21.24M-8.35M
EBITDA Margin15.36%27.93%26.61%27.80%30.00%-0.99%8.08%7.13%-2.61%
Net Income21.59M49.29M48.18M75.14M85.09M-5.63M15.41M17.65M-7.10M
Net Income Margin10.90%23.17%20.54%22.15%24.88%-2.75%5.63%5.92%-2.22%
R&D12.88M13.18M19.31M29.41M32.37M44.52M44.60M43.72M32.05M
R&D as % of Total Revenue6.51%6.19%8.23%8.67%9.46%21.76%16.29%14.67%10.00%
Interest Expense1.58M652.26K549.79K475.83K332.81K496.27K658.82K928.77K950.25K
Interest Expense % of Total Revenue0.80%0.31%0.23%0.14%0.10%0.24%0.24%0.31%0.30%

Balance Sheet

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets255.53M295.74M383.06M431.55M941.07M902.68M947.30M966.95M977.93M
Total Liabilities61.44M50.53M89.44M62.70M70.16M58.53M89.24M104.44M124.52M
Total Equity194.09M245.21M293.55M368.80M870.90M844.20M858.12M862.54M854.21M
Cash125.35M119.40M94.70M95.50M355.51M198.25M242.17M271.91M213.41M
Total Debt20.40M5.34M38.45M4.58M23.36M10.09M10.12M11.83M-
Net Debt-104.95M-114.07M-56.25M-90.92M-332.15M-188.16M-232.05M-260.08M-

Cash Flow

Currency: CNY2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow29.00M32.95M21.59M71.18M31.53M-32.79M21.48M22.62M-72.62M
Investing Cash Flow-39.58M-29.64M-75.18M-30.49M-203.82M-88.16M22.42M-17.40M-
Financing Cash Flow80.24M-22.56M39.31M-35.03M434.52M-45.33M-601.19K-23.68M-
Capital Expenditure1.88M2.46M4.37M6.96M14.07M23.10M43.19M96.20M65.83M
Free Cash Flow27.12M30.49M17.22M64.23M17.46M-55.89M-21.71M-73.59M-138.44M
Dividends Paid1.47M592.60K424.72K363.56K29.96M25.56M34.28K5.02M5.95M
FCF to OCF93.51%92.54%79.76%90.23%55.38%170.44%-101.10%-325.31%190.64%
Dividend Paid to FCF5.43%1.94%2.47%0.57%171.59%-45.73%-0.16%-6.82%-4.30%

Earnings

Report DateMar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023
EPS Estimate---------
EPS Actual0.250.270.190.24-0.080.05-0.01-0.02-0.08
Surprise---------
Timing---------

Key Statistics & Ratios

Market Cap3.13B
Enterprise Value3.53B
Trailing P/E0.00
Forward P/E0.00
Price / Sales9.80
Price / Book4.10
EPS-0.34
Book Value9.59
Revenue (TTM)319.79M
Gross Profit (TTM)101.40M
EBITDA-18.12M
Profit Margin-9.27%
Operating Margin-16.75%
Return on Equity-3.70%
Return on Assets-1.36%
Shares Outstanding88.13M
Shares Float59.43M
Beta0.43
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.06Jun 13, 2025
20241×
0.05Jun 17, 2024
20221×
0.29Jun 24, 2022
20211×
0.34Jul 2, 2021